Core Viewpoint - The company Jianxin Superconducting is preparing for an IPO on the Sci-Tech Innovation Board, aiming to leverage its advancements in superconducting technology and expand its market presence [2][9]. Financial Performance - Jianxin Superconducting's revenue for the years 2022, 2023, and 2024 was 358.93 million yuan, 450.64 million yuan, and 425.50 million yuan respectively, with net profits of 34.63 million yuan, 48.73 million yuan, and 55.78 million yuan, indicating strong financial health [3][4]. - The total assets of the company increased from 527.12 million yuan in 2022 to 671.28 million yuan in 2024, while the equity attributable to shareholders rose from 357.14 million yuan to 473.39 million yuan during the same period [4]. Capital Raising and Investment Plans - The company plans to raise 865 million yuan, with 90 million yuan allocated for working capital and the remainder directed towards projects including the production of 600 sets of helium-free superconducting magnets and high-field medical superconducting magnets [5][6]. Shareholding Structure - The Xu family holds nearly 60% of the company's shares, with Xu Jianyi, Xu Hui, and Xu Dianbo controlling 41.51%, 4.36%, and 4.36% respectively, highlighting a strong family influence in corporate governance [7]. Strategic Importance of IPO - The IPO represents a significant milestone for Jianxin Superconducting, providing access to more resources and opportunities while subjecting the company to stricter regulatory scrutiny [9].

Summary of Key Points Core Viewpoint - The week of May 6 to May 11 saw the acceptance of 2 new IPO applications in the Shanghai and Shenzhen stock exchanges, while 2 companies withdrew their IPO applications, and 1 company received registration approval. Group 1: New IPO Applications - Two new IPO applications were accepted on May 9, including Ningbo Jianxin Superconducting Technology Co., Ltd. for the Shanghai Stock Exchange's Sci-Tech Innovation Board and Hangzhou Lianchuan Biotechnology Co., Ltd. for the Beijing Stock Exchange [1][3] - Jianxin Superconducting is the third company accepted for the Sci-Tech Innovation Board this year, focusing on the R&D, production, and sales of core components for MRI equipment [3] - Jianxin Superconducting reported revenues of 359 million yuan, 451 million yuan, and 425 million yuan for 2022 to 2024, with net profits of 34.63 million yuan, 48.73 million yuan, and 55.78 million yuan respectively [3][4] - Lianchuan Biotechnology previously attempted to list on the Sci-Tech Innovation Board but withdrew its application and is now seeking to raise 300 million yuan, half of its previous target [4] Group 2: Terminated IPO Applications - Two companies withdrew their IPO applications: Wuxi Yelong Precision Machinery Co., Ltd. and Shenzhen Haobo Window Control Technology Co., Ltd. [1][6] - Wuxi Yelong, which specializes in turbocharger components, withdrew its application over a year after approval due to the impact of electric vehicles on its business [6][7] - Haobo Window Control reported a revenue decline of 2.46% in the first half of 2024 and expects a full-year revenue drop of 10.76% to 12.68% [8]